The Pain Pen for Breakthrough Cancer Pain
NCT00125801
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
50
Enrollment
OTHER
Sponsor class
Stopped
Lack of patients
Conditions
Neoplasms
Pain
Interventions
DRUG:
Subcutaneous hydromorphone delivered by pain pen
Sponsor
Erasmus Medical Center